A combination microbicide gel protects macaques against vaginal SHIV-RT infection, but only partially reduces HSV-2 infection after a single high-dose co-challenge (HTML)
Hsu,Mayla; Aravantinou,Meropi; Menon,Radhika; Seidor,Samantha; Goldman,Daniel; Kenney,Jessica; Derby,Nina R.; Gettie,Agegnehu; Blanchard,James; Piatak Jr.,Michael; Lifson,Jeffrey D.; Fernandez-Romero,Jose A.; Zydowsky,Thomas M.; Robbiani,Melissa
AIDS Research and Human Retroviruses Published online ahead of print, 11 October
Publication date: 2013
Herpes simplex virus-2 (HSV-2) infection increases HIV susceptibility. We previously established a rhesus macaque model of vaginal HSV-2 pre-exposure followed by co-challenge with HSV-2 and simian/HIV (SHIV-RT). Using this model, we showed that a gel containing the non-nucleoside reverse transcriptase inhibitor (NNRTI) MIV-150 in carrageenan (CG) reduced SHIV-RT infection. To evaluate the efficacy of new generation microbicides against both viruses, we first established dual infection after single vaginal co-challenge with SHIV-RT and HSV-2 in HSV-2-naïve macaques. All animals (6/6) became HSV-2-infected, with 4 of 6 co-infected with SHIV-RT. In a control group co-challenged with SHIV-RT and UV-inactivated HSV-2, 2 of 4 became SHIV-RT infected, and none had detectable HSV-2. Low-level HSV-2-specific antibody and T cell responses were detected in some HSV-2-infected animals. To test a CG gel containing MIV-150 and zinc acetate (MZC), which provided naïve animals full protection from SHIV-RT for at least 8 hours (h), MZC (vs. CG) was applied daily for 14 days (d) followed by co-challenge 8h later. MZC prevented SHIV-RT infection (0/9 infected, p=0.04 vs. 3/6 in CG controls), but only reduced HSV-2 infection by 20% (6/9 infected vs. 5/6 in CG, p=0.6). In HSV-2-infected animals, none of the gel-treated animals seroconverted, and only the CG controls had measurable HSV-2-specific T cell responses. This study shows the promise of MZC to prevent immunodeficiency virus infection (even in the presence of HSV-2) and reduce HSV-2 infection after exposure to a high-dose inoculum. Additionally, it demonstrates the potential of a macaque co-infection model to evaluate broad-spectrum microbicides.
For 60 years, the Population Council has changed the way the world thinks about important health and development issues. Explore an interactive timeline of the Council's history, learn more about some of our key contributions, and watch a short video about why your support is so important to us.